Theo Manufacturing

Theo is a life sciences technology company developing an automated manufacturing platform designed to scale the production of advanced therapies, such as cell and gene treatments. By integrating software-defined infrastructure with modular hardware, Theo aims to reduce the complexity, cost, and time associated with manufacturing complex biologics. The company's platform provides a bridge between laboratory-scale research and industrial-scale production, enabling biotech firms to accelerate their clinical timelines. Theo's approach focuses on digitizing the manufacturing process to ensure high fidelity and reproducibility across different production sites. Headquartered in San Francisco, the company is backed by prominent venture capital firms and seeks to address the critical manufacturing bottlenecks currently facing the regenerative medicine sector.